Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Healthy meal deliveries boost quality of life for people with heart failure

Providing healthy, medically tailored meals or boxes of fresh produce along with nutrition counseling with a dietitian led to improved quality of life for people with heart failure compared to people who received dietary counseling without healthy food deliveries, according to a preliminary late-breaking science presentation today at the American Heart Association's Scientific Sessions 2025.

10 Nov 2025

MRI-based blood flow testing offers better answers for unexplained chest pain

Chest pain may still be angina even when coronary angiogram testing shows the main heart arteries look clear. Using stress cardiac stress MRI testing to measure blood flow around the heart appears to improve diagnosis and patient quality of life.

10 Nov 2025

GLP-1 drugs beat metformin for weight control in teens with type 2 diabetes

In youth newly diagnosed with type 2 diabetes, GLP-1–based therapies, including semaglutide and tirzepatide, achieved similar blood sugar control but significantly greater reductions in body mass index than metformin. These findings highlight the potential of high-potency GLP-1 agents as effective monotherapy options in managing obesity and glycemic control in adolescents.

10 Nov 2025

Diabetes drugs semaglutide and tirzepatide show real-world heart benefits

In a large real-world analysis across three U.S. healthcare databases, semaglutide and tirzepatide showed cardiovascular benefits consistent with randomized trials. Semaglutide lowered heart attack and stroke risk versus sitagliptin, while tirzepatide performed comparably to dulaglutide and semaglutide over one year.

10 Nov 2025

Type 2 diabetes patients face an elevated risk of hearing loss

As the United States observes American Diabetes Month this November, a comprehensive study published in Otolaryngology–Head and Neck Surgery, the peer-reviewed journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation, reveals that individuals with type 2 diabetes face a significantly elevated risk of hearing loss-a complication that often goes unrecognized and unscreened.

10 Nov 2025

Weill Cornell scientists discover early step in fat cell inflammation leading to diabetes

Weill Cornell Medicine investigators have identified an early step in a cellular process that leads to inflammation in fat cells and may result in type 2 diabetes in people with obesity.

10 Nov 2025

Weight loss drugs used by patients with high triglycerides do not increase pancreatitis risk

In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by patients who have high triglycerides do not increase their risk of pancreatitis or adverse cardiac events.

10 Nov 2025

Maternal type 1 diabetes may protect children from developing the disease

Findings suggest maternal T1D exposure leads to protective epigenetic alterations in children, influencing immune response and type 1 diabetes susceptibility.

10 Nov 2025

Genetic and cellular mechanisms underlying steatotic liver disease

Steatotic liver disease (SLD), mainly encompassing metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic dysfunction and ALD (MetALD), has emerged as the dominant cause of chronic liver disease worldwide, displacing viral hepatitis as the primary aetiology.

10 Nov 2025

How modern habits are reshaping the Mediterranean diet for the worse

Nearly all children and adolescents in five Mediterranean countries consume unhealthy ultra-processed foods daily, according to the DELICIOUS Project. The study links higher intake to obesity, older age, screen time, eating out, and exposure to food advertising.

9 Nov 2025

Preclinical evidence supports sotagliflozin's superior efficacy in attenuating salt-induced kidney damage

Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and kidney- protective effects. In the kidney, SGLT2 reabsorbs approximately 97% offiltered glucose in the S1 and S2 segments of the proximal tubule, while SGLT1reabsorbs the remainder in the S3 segment.

8 Nov 2025

SGLT2 inhibitors show consistent cardio-renal protection in 70,000 patients

In late-breaking presentations at the American Society of Nephrology Kidney Week meeting and simultaneously published in two companion papers in JAMA, the findings are based on data from over 70,000 participants across 10 major randomised controlled trials. The meta-analyses were conducted by the SGLT2 Inhibitor Meta-analysis Cardio-Renal Trialists' Consortium (SMART-C), led by The George Institute for Global Health.

7 Nov 2025

Diabetes drug blunts exercise-induced health improvements

A widely prescribed diabetes drug may be sabotaging one of the most trusted strategies for preventing the disease: exercise.

7 Nov 2025

How diet affects aging metabolism differently for men and women

Research reveals sex-based differences in diet's impact on metabolism, highlighting plant proteins for men and moderate wine for women in older adults.

7 Nov 2025

Scientists turn human stomach cells into insulin-producing beta cells

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and estimated to affect 9.5 million people worldwide.

6 Nov 2025

Finerenone offers hope for kidney protection in patients with type 1 diabetes

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease.

6 Nov 2025

Maternal type 1 diabetes confers a protective effect in children through epigenetic programming

Children with a family history of type 1 diabetes (T1D) have an increased risk of developing the disease.

6 Nov 2025

New tool reveals hidden psychological reasons behind patients ignoring medication plans

A pioneering patient-reported outcome tool, developed by healthcare company Observia with the support of Kingston University, has shown significant promise in predicting the risk of a patient with chronic conditions not following their treatment plan, while also uncovering the deep psychological and social reasons driving the patient's decision making.

5 Nov 2025

Researchers uncover molecular key to prevent brown fat decline with age

As the body ages, brown adipose tissue activity decreases, fewer calories are burned, and this can contribute to obesity and certain chronic cardiovascular diseases that worsen with age.

5 Nov 2025

Senotherapeutics mitigate the root drivers of age- and obesity-related metabolic disease

A growing body of evidence implicates cellular senescence-when cells age and permanently stop dividing-as an important contributor to metabolic dysfunction that can lead to obesity, type 2 diabetes, and metabolic syndrome.

5 Nov 2025

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Healthy meal deliveries boost quality of life for people with heart failure

MRI-based blood flow testing offers better answers for unexplained chest pain

GLP-1 drugs beat metformin for weight control in teens with type 2 diabetes

Diabetes drugs semaglutide and tirzepatide show real-world heart benefits

Type 2 diabetes patients face an elevated risk of hearing loss

Weill Cornell scientists discover early step in fat cell inflammation leading to diabetes

Weight loss drugs used by patients with high triglycerides do not increase pancreatitis risk

Maternal type 1 diabetes may protect children from developing the disease

Genetic and cellular mechanisms underlying steatotic liver disease

How modern habits are reshaping the Mediterranean diet for the worse

Preclinical evidence supports sotagliflozin's superior efficacy in attenuating salt-induced kidney damage

SGLT2 inhibitors show consistent cardio-renal protection in 70,000 patients

Diabetes drug blunts exercise-induced health improvements

How diet affects aging metabolism differently for men and women

Scientists turn human stomach cells into insulin-producing beta cells

Finerenone offers hope for kidney protection in patients with type 1 diabetes

Maternal type 1 diabetes confers a protective effect in children through epigenetic programming

New tool reveals hidden psychological reasons behind patients ignoring medication plans

Researchers uncover molecular key to prevent brown fat decline with age

Senotherapeutics mitigate the root drivers of age- and obesity-related metabolic disease

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in